图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
免疫病理疾病及治疗学论文学
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN 打印: 2151-8017
ISSN 在线: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

免疫病理疾病及治疗学论文学

DOI: 10.1615/ForumImmunDisTher.2016016605
pages 143-156

Tissue Cross-Talk and Exosomal-MicroRNAs

Micol Marchetti
Bristol Renal, University of Bristol, Dorothy Hocking Building, Whitson Street, BS1 3NY, Bristol, UK

ABSTRACT

Over the last 10 years, the interest in microRNAs has grown rapidly, and the characterization of these short non-coding RNA sequences has become crucial due to their involvement and role in several widespread diseases such as cancer, cardiovascular diseases, kidney diseases, and diabetes, as well as developmental diseases. The increased understanding of the biology of microRNAs has triggered the development of important tools to study their function and new therapeutic opportunities to treat disease, offering a clear example of how the scientific translational approach plays a crucial role in scientific research in the 21st century. More recently, this interest in microRNAs has increased further as a result of the discovery of exosome microRNAs, microRNAs contained in endogenous vesicles isolated from biological fluids such as breast milk, blood, serum, urine, cerebrospinal fluid, and semen. MicroRNAs represent powerful potential biomarkers for the detection of diseases at an early stage, when the chances of successful treatment and outcomes (drug mediated or surgical) are higher. Furthermore, recent publications have highlighted the role of exosomal microRNAs in cell-to-cell communication, adding new information to the importance of these exosome and vesicles. Much work still needs to be done to better understand the biogenesis and loading and dispersion of exosomes and microvesicles as well to characterize the exosomal content in terms of functionality and activity, but current data already suggest that these exosomes could be potential therapeutic targets.


Articles with similar content:

Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 2
Rama Rao Malla, Deepak KGK, L. Srinivas, Deepthi S
Human Immunodeficiency Virus Type 1 Pharmacogenomics in Clinical Practice: Relevance of HIV-1 Drug Resistance Testing (Part 1)
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 3
Nancy G. Klimas, Margaret Marchette, Charles Mitchell, Eduardo Meneses Sierra, Alejandro Isava, Dushyantha Jayaweera, Enriqueta Nunez, J. Brian Page, Gwendolyn Scott, Roberto Patarca, Nelson J. Rodriguez, Mary Ann Fletcher, Delia Rivera, Michael Kolber, Mirtha M. Sanabia, Rafael Campo, Cindy W. Mask, Jose Moreno, Michael Alter, Ricardo Vallejo, Catherine Boulanger
Human Immunodeficiency Virus Type 1 Pharmacogenomics in Clinical Practice: Relevance of HIV-1 Drug Resistance Testing (Part 2)
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 4
Nancy G. Klimas, Margaret Marchette, Charles Mitchell, Eduardo Meneses Sierra, Alejandro Isava, Dushyantha Jayaweera, Enriqueta Nunez, J. Brian Page, Gwendolyn Scott, Roberto Patarca, Nelson J. Rodriguez, Mary Ann Fletcher, Delia Rivera, Michael Kolber, Mirtha M. Sanabia, Rafael Campo, Cindy W. Mask, Jose Moreno, Michael Alter, Ricardo Vallejo, Catherine Boulanger
Possible Role of Epidermal Growth Factor Receptors in the Therapy of Pancreatic Cancer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.28, 2011, issue 4
R. S. R. Murthy, Suresh P. Vyas, Manish K. Gupta, Sahil Aggarwal, Swati Gupta
The Nuclear Receptor PXR: A Master Regulator of “Homeland” Defense
Critical Reviews™ in Eukaryotic Gene Expression, Vol.12, 2002, issue 1
Barry Marc Forman, Isabelle Dussault